Transdifferentiation of GBM tumor-derived endothelial cells has been documented by multiple groups [30], [31], [32] and CXCL12 has been reported to promote in vitro tube formation and VEGF production of endothelial cells [18], [19]. This evidence concerns the gene CXCL12 and glioblastoma.